Hsu SJ, Chao YC, Wang SW, Zheng QY, et al. Stereotactic Body Radiation Therapy With Continued First-Line PD-1 Inhibitor-based Therapy as a Resistance-Overcoming Strategy in Oligoprogressive Hepatocellular Carcinoma: A Prospective Phase 2 Clinical Study. Int J Radiat Oncol Biol Phys 2026;124:1388-1398.
PMID: 41520893